NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

REVASUM INC. (RVS)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of RVS: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services Limited Sydney
Level 12, 680 George Street Sydney NSW 2000
Tel : 61 1300 554 474
Fax : 02 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000030959
Address: C/- Incorporating Services Ltd, 3500 South Dupont Highway, DOVER, DEL, UNITED STATES OF AMERICA, 19901
Tel:  +1 (805) 541-6424

Date first listed: 04/12/2018

Activities: Designs, manufactures and markets a portfolio of semiconductor processing equipment

News & Events

Expand this box to read and print

The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

10/07/2024

ASX will continue to suspend trading of the Company's CDIs until such time as it lodges its annual financial report. The Company has been unable to lodge its annual financial report and Appendix 4E for 2023 while it works through the process of identifying strategic and financing options to secure its future. As mentioned in its last press release, the Company is exploring strategic options to maximize stockholder value and has received multiple indications of interest from potential partners. The process is ongoing, but it is difficult to anticipate the potential duration of the process. The Company is hopeful that the process can be concluded in a timely fashion and that it can resume lodgement of its periodic reports shortly thereafter.

19/03/2024

ASX has agreed to extend the voluntary suspension of the Company's CDIs for up to a further two weeks while the Company continues to pursue Its strategic process. The Company's investment bank, B Riley Financial, has received multiple indications of interest with respect to a potential acquisition of the Company. At least one party has indicated it would need another week or two before it can complete its due diligence with a goal of presenting an indicative offer to the Company. The Company has therefore agreed to give additional time to that party. The Company has continued the streamlining of its cost structure including the previously announced furlough of its employees. The Company has also continued to experience delay in receiving payments from customers and is currently working on securing additional financing as well as renegotiating default forbearance terms with its creditors. The securing of such additional financing and the renegotiation with its creditors are critical to the Company's success and the Company believes that continued trading in its securities is likely to be materially prejudicial to its ability to complete such a transaction that is critical to is continued financial viability. The Company also advises that it has entered into certain management incentive and retention arrangements with the Chief Executive Officer and Chief Financial Officer of the Company whereby those executives might receive incentive compensation in the event of a successful sale transaction.

04/03/2024

The securities of Revasum Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of RVS, pending the release of an announcement regarding its funding, an update to its strategic process and/or other material updates.

05/02/2024

listed entity carried for record purposes only

04/12/2018

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    27/12/2019Jerry Cutini100,000$0.031
    USD
    $3,133
    18/12/2019Jerry Cutini10,000$0.720
    CDI
    $7,200
    29/08/2019Jerry Cutini37,500$1.441
    CDI
    $54,019
    17/05/2019Jerry Cutini37,500$1.360
    CDI
    $51,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Kevin LandisNon Exec Chairman04/12/2018
    Alejandro GarciaCOO03/01/2022
    Bruce RayCFO, Company Secretary12/09/2022
    Paul MirabelleDirector04/12/2018
    Scott JewlerDirector, CEO02/08/2022

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Ryan BentonCFO04/12/201831/10/2023
    Bill KalenianInterim CEO23/05/202202/08/2022
    Rebecca Shooter-DoddExecutive Director, CEO01/11/202023/05/2022
    Vivek RaoChairman04/12/201828/09/2021
    Jerry CutiniPresident, CEO04/12/201829/12/2020

    Date of first appointment, title may have changed.